{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T14:15:51Z","timestamp":1780582551370,"version":"3.54.1"},"reference-count":25,"publisher":"American Society for Microbiology","issue":"2","license":[{"start":{"date-parts":[[1998,2,1]],"date-time":"1998-02-01T00:00:00Z","timestamp":886291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[1998,2]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            Nine isolates of filamentous fungi previously tested in 11 different laboratories for their susceptibilities to amphotericin B and itraconazole in vitro were injected intravenously into mice and guinea pigs, and responses to treatment with both agents were studied. The experiments were done in a single laboratory. Mean survival times, the percentages of animals surviving 12 days after infection, and culture results for samples of deep organs obtained postmortem were used as markers of antifungal efficacy. Because of variations in organism pathogenicity, interpretable test systems in vivo could not be established for\n            <jats:italic>Fusarium<\/jats:italic>\n            spp. in mice or guinea pigs or for\n            <jats:italic>Pseudallescheria boydii<\/jats:italic>\n            in mice, even with the use of immunosuppressive pretreatments. Among the infections that could be evaluated, some degree of response to the corresponding treatment in vivo was seen in animals infected with each of two\n            <jats:italic>Rhizopus arrhizus<\/jats:italic>\n            isolates susceptible to amphotericin B at &lt;0.5 \u03bcg\/ml and\n            <jats:italic>Aspergillus<\/jats:italic>\n            spp. isolates susceptible to itraconazole at &lt;1.0 \u03bcg\/ml. Conversely, no responses were apparent with infecting strains for which MICs were \u22652 \u03bcg\/ml (amphotericin B) or \u22651 \u03bcg\/ml (itraconazole). However, the limitations of the intravenous challenge systems studied mean that no firm conclusion relating MICs in vitro to the lowest effective doses in vivo could be drawn.\n          <\/jats:p>","DOI":"10.1128\/aac.42.2.282","type":"journal-article","created":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T16:18:56Z","timestamp":1585930736000},"page":"282-288","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":114,"title":["Evaluation of Possible Correlations between Antifungal Susceptibilities of Filamentous Fungi In Vitro and Antifungal Treatment Outcomes in Animal Infection Models"],"prefix":"10.1128","volume":"42","author":[{"given":"F. C.","family":"Odds","sequence":"first","affiliation":[{"name":"<!--label omitted: 1-->Department of Bacteriology and Mycology, Janssen Research Foundation, Beerse, Belgium1;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Van Gerven","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Department of Bacteriology and Mycology, Janssen Research Foundation, Beerse, Belgium1;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Espinel-Ingroff","sequence":"additional","affiliation":[{"name":"<!--label omitted: 2-->Medical College of Virginia, Virginia Commonwealth University, Richmond, Virginia2;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. S.","family":"Bartlett","sequence":"additional","affiliation":[{"name":"<!--label omitted: 3-->Indiana University Medical Center, Indianapolis, Indiana3;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. A.","family":"Ghannoum","sequence":"additional","affiliation":[{"name":"<!--label omitted: 4-->Center for Medical Mycology, Cleveland, Ohio4;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. V.","family":"Lancaster","sequence":"additional","affiliation":[{"name":"<!--label omitted: 5-->Antimicrobial Resistance Section, Centers for Disease Control and Prevention, Atlanta, Georgia5;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. A.","family":"Pfaller","sequence":"additional","affiliation":[{"name":"<!--label omitted: 6-->Special Microbiology Laboratory, University of Iowa College of Medicine, Iowa City, Iowa6;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. H.","family":"Rex","sequence":"additional","affiliation":[{"name":"<!--label omitted: 7-->Division of Infectious Diseases, Department of Internal Medicine, Center for the Study of Emerging and Reemerging Pathogens, University of Texas Medical School, Houston, Texas7;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. G.","family":"Rinaldi","sequence":"additional","affiliation":[{"name":"<!--label omitted: 8-->Department of Pathology, University of Texas Health Science Center, San Antonio, Texas8; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. J.","family":"Walsh","sequence":"additional","affiliation":[{"name":"<!--label omitted: 9-->Pediatric Branch, National Cancer Institute, Bethesda, Maryland9"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.35.9.1721"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/170.2.384"},{"key":"e_1_3_2_4_2","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1093\/infdis\/172.3.823","article-title":"Cytokine mRNA in brain tissue from mice that show strain-dependent differences in the severity of lesions induced by systemic infection with Candida albicans yeast.","volume":"172","author":"Ashman R. B.","year":"1995","unstructured":"Ashman R. B. Bolitho E. M. Fulurija A. Cytokine mRNA in brain tissue from mice that show strain-dependent differences in the severity of lesions induced by systemic infection with Candida albicans yeast. J. Infect. Dis. 172 1995 823 830","journal-title":"J. Infect. Dis."},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.40.5.1317"},{"key":"e_1_3_2_6_2","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/jac\/30.3.353","article-title":"Efficacies of amphotericin B lipid complex (ABLC) and conventional amphotericin B against murine coccidioidomycosis.","volume":"30","author":"Clemons K. V.","year":"1992","unstructured":"Clemons K. V. Stevens D. A. Efficacies of amphotericin B lipid complex (ABLC) and conventional amphotericin B against murine coccidioidomycosis. J. Antimicrob. Chemother. 30 1992 353 363","journal-title":"J. Antimicrob. Chemother."},{"key":"e_1_3_2_7_2","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/BF01138472","article-title":"Discrepancies between MIC and MLC values of amphotericin B against isolates of Aspergillus species.","volume":"128","author":"Colombo A. L.","year":"1994","unstructured":"Colombo A. L. McGough D. A. Rinaldi M. G. Discrepancies between MIC and MLC values of amphotericin B against isolates of Aspergillus species. Mycopathologia 128 1994 129 133","journal-title":"Mycopathologia"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/icb.1995.20"},{"key":"e_1_3_2_9_2","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0002-9343(94)90023-X","article-title":"NIAID mycoses study group multicenter trial of oral itraconazole therapy of invasive aspergillosis.","volume":"97","author":"Denning D. W.","year":"1994","unstructured":"Denning D. W. Lee J. Y. Hostetler J. S. Pappas P. Kauffman C. A. Dewsnup D. H. Galgiani J. N. Graybill J. R. Suger A. M. Catanzaro A. Galli H. Perfect J. R. Dockery B. Dismukes W. E. Stevens D. A. NIAID mycoses study group multicenter trial of oral itraconazole therapy of invasive aspergillosis. Am. J. Med. 97 1994 135 144","journal-title":"Am. J. Med."},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.29.2.393-394.1991"},{"key":"e_1_3_2_11_2","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1128\/jcm.35.1.139-143.1997","article-title":"Multicenter evaluation of proposed standardized procedure for antifungal susceptibility testing of filamentous fungi.","volume":"35","author":"Espinel-Ingroff A.","year":"1996","unstructured":"Espinel-Ingroff A. Rex J. H. Bowden R. Menezes P. Bartlett M. McGinnis M. Cooper C. Odds F. C. Pfaller M. Messer S. A. Nelson P. W. Rinaldi M. G. Fothergill A. Shankland G. Walsh T. J. Peter J. Weitzman I. Chin N. X. Multicenter evaluation of proposed standardized procedure for antifungal susceptibility testing of filamentous fungi. J. Clin. Microbiol. 35 1996 139 143","journal-title":"J. Clin. Microbiol."},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.39.2.314"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.39.8.1885"},{"key":"e_1_3_2_14_2","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1093\/infdis\/164.5.944","article-title":"Experimental fusarial hyalohyphomycosis in a murine model.","volume":"164","author":"Legrand C.","year":"1991","unstructured":"Legrand C. Anaissie E. Hashem R. Nelson P. Bodey G. P. Ro J. Experimental fusarial hyalohyphomycosis in a murine model. J. Infect. Dis. 164 1991 944 948","journal-title":"J. Infect. Dis."},{"key":"e_1_3_2_15_2","doi-asserted-by":"crossref","unstructured":"Matsumoto T. L. Ajello T. Matsuda P. J. Szaniszlo and T. J. Walsh. 1994. Developments in hyalohyphomycosis and phaeohyphomycosis. J. Med. Vet. Mycol. 32 (Suppl. 1) : 329\u2013349.","DOI":"10.1080\/02681219480000951"},{"key":"e_1_3_2_16_2","unstructured":"National Committee for Clinical Laboratory Standards\n          Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard M27-A.\n          1997\n          National Committee for Clinical Laboratory Standards\n          Villanova Pa"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/24.2.235"},{"key":"e_1_3_2_18_2","first-page":"32","article-title":"Oral and parenteral treatment with itraconazole in various superficial and systemic experimental fungal infections. Comparisons with other antifungals and combination therapy.","volume":"71","author":"Van Cutsem J.","year":"1990","unstructured":"Van Cutsem J. Oral and parenteral treatment with itraconazole in various superficial and systemic experimental fungal infections. Comparisons with other antifungals and combination therapy. Br. J. Clin. Pract. Suppl. 71 1990 32 40","journal-title":"Br. J. Clin. Pract. Suppl."},{"key":"e_1_3_2_19_2","doi-asserted-by":"crossref","unstructured":"Vartivarian S. E. E. J. Anaissie and G. P. Bodey. 1993. Emerging fungal pathogens in immunocompromised patients: classification diagnosis and management. Clin. Infect. Dis. 17 (Suppl. 2) : S487\u2013S491.","DOI":"10.1093\/clinids\/17.Supplement_2.S487"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/168.2.508"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.39.5.1065"},{"key":"e_1_3_2_22_2","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/infdis\/166.1.121","article-title":"Experimental Trichosporon infection in persistently granulocytopenic rabbits\u2014implications for pathogenesis, diagnosis and treatment of an emerging opportunistic mycosis.","volume":"166","author":"Walsh T. J.","year":"1992","unstructured":"Walsh T. J. Lee J. W. Melcher G. P. Navarro E. Bacher J. Callender D. Reed K. D. Wu T. Lopez-Berestein G. Pizzo P. A. Experimental Trichosporon infection in persistently granulocytopenic rabbits\u2014implications for pathogenesis, diagnosis and treatment of an emerging opportunistic mycosis. J. Infect. Dis. 166 1992 121 133","journal-title":"J. Infect. Dis."},{"key":"e_1_3_2_23_2","doi-asserted-by":"crossref","first-page":"S139","DOI":"10.1093\/clinids\/14.Supplement_1.S139","article-title":"Experimental antifungal chemotherapy in granulocytopenic animal models of disseminated candidiasis\u2014approaches to understanding investigational antifungal compounds for patients with neoplastic diseases.","volume":"14","author":"Walsh T. J.","year":"1992","unstructured":"Walsh T. J. Lee J. W. Roilides E. Francis P. Bacher J. Lyman C. A. Pizzo P. A. Experimental antifungal chemotherapy in granulocytopenic animal models of disseminated candidiasis\u2014approaches to understanding investigational antifungal compounds for patients with neoplastic diseases. Clin. Infect. Dis. 14 1992 S139 S147","journal-title":"Clin. Infect. Dis."},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.28.7.1616-1622.1990"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.39.6.1361"},{"key":"e_1_3_2_26_2","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/0378-4347(87)80249-9","article-title":"Determination of itraconazole in plasma and animal tissues by high-performance liquid chromatography.","volume":"413","author":"Woestenborghs R.","year":"1987","unstructured":"Woestenborghs R. Lorreyne W. Heykants J. Determination of itraconazole in plasma and animal tissues by high-performance liquid chromatography. J. Chromatogr. Biomed. Appl. 413 1987 332 337","journal-title":"J. Chromatogr. Biomed. Appl."}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.42.2.282","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.42.2.282","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T15:42:55Z","timestamp":1645458175000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.42.2.282"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,2]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1998,2]]}},"alternative-id":["10.1128\/AAC.42.2.282"],"URL":"https:\/\/doi.org\/10.1128\/aac.42.2.282","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,2]]},"assertion":[{"value":"1997-04-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"1997-11-17","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"1998-02-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}